Cytotoxicity of ventricular cerebrospinal fluid from Parkinson patients: Correlation with clinical profiles and neurochemistry

By Mandybur George T.   Miyagi Yasushi   Yin Wei   Perkins Eddie   Zhang John H.  

Neurological Research, Vol. 25, Iss. 1, 2003-01 ,pp. : 104-111

Maney Publishing

Access to resources Recommend Favorite

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

By Zhang Jing   Mattison Hayley   Liu Changqin   Ginghina Carmen   Auinger Peggy   McDermott Michael   Stewart Tessandra   Kang Un   Cain Kevin   Shi Min  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 671-682

Springer Publishing Company

Access to resources Recommend Favorite

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects

By Maarouf Chera L   Beach Thomas G   Adler Charles H   Shill Holly A   Sabbagh Marwan N   Wu Terence   Walker Douglas G   Kokjohn Tyler A   Roher Alex E   PD Consortium Arizona  

Neurological Research, Vol. 34, Iss. 7, 2012-09 ,pp. : 669-676

Maney Publishing

Access to resources Recommend Favorite

Cerebrospinal Fluid froml-Dopa-Treated Parkinson's Disease Patients Is Dystrophic for Various Neural Cell Typesex vivo:Effects of Astroglia

By Colombo J.A.   Napp M.I.  

Experimental Neurology, Vol. 154, Iss. 2, 1998-12 ,pp. : 452-463

Elsevier

Access to resources Recommend Favorite

TGF 1 and TGF 2 Concentrations Are Elevated in Parkinson's Disease in Ventricular Cerebrospinal Fluid

By Vawter M.P.   Dillon-Carter O.   Tourtellotte W.W.   Carvey P.   Freed W.J.  

Experimental Neurology, Vol. 142, Iss. 2, 1996-12 ,pp. : 313-322

Elsevier

Access to resources Recommend Favorite